Cerebral metabolic rate of oxygen (CMRO 2 ), the rate at which O 2 is consumed in the brain by metabolic processes, is one of the most useful measures of normal brain function. The present study investigated the use of near-infrared spectroscopy (NIRS) in the noninvasive measurement of O 2 extraction fraction (OEF) and CMRO 2 in the newborn piglet. Indomethacin, although used successfully to effect closure of patent ductus arteriosus in the preterm infant, is known to cause transient reductions in cerebral blood flow (CBF) in both infant and adult humans and pigs. As a test of the NIRS method, the present study also examined the effect of indomethacin-induced reductions in CBF on both OEF and CMRO 2 . CBF, OEF, and CMRO 2 were assessed in 20 newborn piglets, 0.2-3.0 d old. Ten piglets received 0.2 mg/kg of indomethacin infused over 30 min; remaining piglets received saline infusion as control. CBF, OEF, and CMRO 2 measurements were performed before infusion and at 30-min intervals for a period of 90 min post-infusion. Saline infusion elicited no response in CBF, OEF, or CMRO 2 . Immediately after indomethacin infusion, CBF decreased 18.1% below (p Ͻ 0.05) and OEF increased 26.2% above (p Ͻ 0.05) preinfusion values, whereas CMRO 2 showed no significant changes throughout the study. Both CBF and OEF returned to baseline within 60 min after infusion of indomethacin. The proficiency of NIRS in the measurement of OEF and CMRO 2 was demonstrated through the observation of transient increases in OEF, which served to maintain CMRO 2 during indomethacin-induced reductions in CBF. Cerebral metabolic rate of oxygen (CMRO 2 ), the rate at which O 2 is consumed in the brain by metabolic processes, is a key indicator of normal brain function. A means of accurately, noninvasively measuring CMRO 2 at the bedside would provide vital information in the clinical assessment of preterm infants. However, difficulties associated with bedside measurement of cerebral blood flow (CBF) and O 2 extraction fraction (OEF) in the brain have prevented the development of clinically viable CMRO 2 measurement techniques and the widespread clinical use of CMRO 2 as an indicator of proper brain function. The near-infrared spectroscopy (NIRS) system used in the present study allows for quantitative measurement of both CBF and OEF at the bedside and thus may provide a clinically useful means of measuring CMRO 2 in the newborn human infant.
Cerebral metabolic rate of oxygen (CMRO 2 ), the rate at which O 2 is consumed in the brain by metabolic processes, is a key indicator of normal brain function. A means of accurately, noninvasively measuring CMRO 2 at the bedside would provide vital information in the clinical assessment of preterm infants. However, difficulties associated with bedside measurement of cerebral blood flow (CBF) and O 2 extraction fraction (OEF) in the brain have prevented the development of clinically viable CMRO 2 measurement techniques and the widespread clinical use of CMRO 2 as an indicator of proper brain function. The near-infrared spectroscopy (NIRS) system used in the present study allows for quantitative measurement of both CBF and OEF at the bedside and thus may provide a clinically useful means of measuring CMRO 2 in the newborn human infant.
As a test of the NIRS method, the present study investigated the effect of the nonsteroidal anti-inflammatory drug indomethacin on both OEF and CMRO 2 in the anesthetized newborn piglet. Indomethacin is currently used in the treatment of patent ductus arteriosus (PDA), a common condition among preterm infants that has been shown to increase the risk of intraventricular hemorrhage, bronchopulmonary dysplasia, and death in this group (1) . Although useful in the treatment of PDA, administration of indomethacin is known to cause a transient reduction in CBF in both human and animal newborns (2-4).
Because reductions in CBF compromise O 2 delivery, concern has been raised as to whether indomethacin administration may also alter CMRO 2 . Several studies previously reported in the literature have investigated the effect of indomethacin on CMRO 2 in newborn human and animal models with varying results (2, (5) (6) (7) , likely attributable to different indomethacin doses used and to differences in techniques used for CMRO 2 measurement. Benders et al. (5) , inferring CMRO 2 from cytochrome oxidase (Cyt) measurement, and Pourcyrous et al. (2) , using microsphere-measured CBF and venous (sagittal sinus) blood samples to calculate CMRO 2 , both observed a decrease in CMRO 2 after indomethacin infusion in preterm infants (indomethacin dose of 1 mg/kg) and newborn piglets (3-5 d old; indomethacin dose of 5 mg/kg), respectively, whereas van Bel et al. (6) found indomethacin administration (1 mg/kg) had no effect on CMRO 2 in the fetal lamb. Coyle et al. (7) found that high-dose (5 mg/kg) indomethacin elicited a decrease in CMRO 2 , whereas lower-dose (3 mg/kg) indomethacin treatment had no effect in newborn piglets 3-5 d old, reporting that increases in OEF during indomethacin-induced reductions in CBF were sufficient to maintain CMRO 2 in the lower dose group. In the present study, we sought to demonstrate the ability of NIRS to measure noninvasively both OEF and CMRO 2 in the newborn piglet using, as a test of the NIRS measurements, transient increases in OEF that serve to maintain CMRO 2 during indomethacin-induced reductions in CBF.
METHODS
Theory. NIRS has been used in a variety of studies to investigate cerebral hemodynamics since the first publication by Jobsis in 1977 (8 -10) . The underlying principles behind the use of NIRS to probe biologic media are relatively simple and have been described in detail elsewhere (8, (11) (12) (13) (14) (15) . There exist in biologic tissue four endogenous NIR light absorbers, oxy-Hb (HbO 2 ), deoxy-Hb (Hb), Cyt, and water. Because HbO 2 and Hb are generally present at relatively low concentrations in tissue, NIR light is able to penetrate tissue to a greater extent than other frequencies of light, in some cases up to distances of 8 -9 cm (13) .
As NIR light enters tissue, it is multiply scattered. This scatter increases the total pathlength traveled by NIR light such that the actual pathlength is greater than the physical distance between the points of emission and detection. The increase in distance can be accounted for using the differential pathlength factor (DPF) first described by Delpy et al. (16) . With accurate knowledge of the DPF, a modified version of the Beer-Lambert law can be used to determine absolute changes in concentrations of NIR absorbers within tissue:
where ⌬c is the change in concentration, ⌬A is the change in attenuation, ␣ is the extinction coefficient, L is the physical distance between emission and detection of NIR light, and B is the DPF. We used a cooled CCD spectrometer to acquire high signal-to-noise NIR spectra from 600 to 980 nm with a spectral sampling width of 0.395 Ϯ 0.001 nm. The acquired spectra enable the DPF to be estimated using the second derivative technique, as described by Matcher et al. (17) .
For a complete discussion of the use of NIRS to measure CBF, cerebral blood volume (CBV), and mean transit time (MTT), see Brown et al. (18) . Briefly, the technique requires i.v. administration of the NIR chromophore indocyanine green (ICG). CBF, CBV, and MTT calculations are based on deconvolution as discussed below. If we consider a network of capillaries in a certain mass of brain tissue, then CBF into the network is F (mL · min Ϫ1 · 100 g Ϫ1 ) and is carrying with it ICG at concentration of C a (t) (mol/mL). The tissue concentration function, or the tissue residue function, Q(t) (mol/mL), can be measured using NIRS. In the special case when F · C a is a delta function such that a unit mass of ICG is deposited in the tissue instantaneously at time 0, the tissue residue function becomes the impulse residue function (IRF) or R(t) (19) . The length of the initial plateau of the IRF at unity height corresponds to the minimum time required for the blood to traverse the network from the arterial inlet to the venous outlet, or the minimum transit time.
When ICG is injected i.v. at a peripheral vein, the rate of delivery of the tracer to the capillary network is F · C a (t). If the mass of ICG in the network is linear with respect to the arterial (input) concentration and F is constant in time, then by linear superimposition, it can be shown that
where * is the convolution operator. Q(t) and C a (t) can be measured by NIRS, and deconvolution between the two curves then yields F · R(t) (20) , the initial height of which corresponds to CBF and the area under the curve to CBV (21) . From the Central Volume Principle (22) , MTT can then be calculated as follows:
MTT ϭ CBV CBF Arterial oxygen saturation (SaO 2 ) was calculated from partial arterial oxygen tension (PaO 2 ), measured from arterial blood samples, using the method described by Kelman et al. (23) .
Arterial oxygen content was calculated using SaO 2 as follows:
where CaO 2 is arterial oxygen content and SaO 2 and PaO 2 are arterial oxygen saturation and oxygen tension, respectively. The first part of the equation describes the amount of oxygen bound to Hb; the second part describes the amount of oxygen dissolved in plasma. Our calculations showed the amount of oxygen dissolved in plasma to be negligible, and we therefore omitted it from CaO 2 calculations. Although the NIRS system described has the capability to accurately measure absolute Hb concentration in a given volume of tissue, it is unable to provide reliable measures of absolute HbO 2 concentration. However, it is possible to use only absolute Hb concentrations to determine arteriovenous O 2 862 difference when both CBV and the distribution of CBV into arterial, capillary, and venous compartments are known. Firstly, CBV expressed in milliliters per unit volume of brain tissue (equal to CBV expressed in milliliters per unit mass of brain tissue multiplied by the density of brain tissue, 1.05 g/mL) can be viewed as the dilution factor of the NIRS measurements, relative to blood sampling measurements. Thus, NIRS measurements can be converted into equivalent blood sampling unit by division with the factor CBV * , where is the density of brain tissue. Second, NIRS measurements do not distinguish between the arterial, capillary, and venous compartments of the cerebral circulation and thus reflect a weighted average of Hb concentrations within these different blood compartments in the region sampled. The relative distribution of arterial, capillary, and venous compartments in the CBV is generally accepted to be approximately 20%, 10%, and 70% respectively (24) . Using this distribution, [Hb] in the venous compartment can be isolated as follows: 
OEF, the percentage of oxygen extracted from arterial blood in the brain, was calculated using the method described by Mintun et al. (25, 26) 
Subjects and studies. Twenty newborn piglets were studied. The study was approved by the Council on Animal Care, Animal Use Sub-Committee at the University of Western Ontario. Piglets were anesthetized using 1% isoflurane, paralyzed with vecuronium, intubated, and ventilated. Physiologic parameters, including pH, partial arterial CO 2 tension (PaCO 2 ), partial arterial O 2 tension (PaO 2 ), heart rate, mean arterial blood pressure, and temperature, were monitored throughout the experiment. Table 1 ) received an equivalent volume of vehicle (saline), infused over 30 min, as control. Indomethacin dose and administration regimens were chosen to match those used in the clinical treatment of PDA. NIRS CBF, CBV, and MTT measurements were performed before infusion (either 30 min or 5 min before the start of infusion), directly after infusion, and at 30-min intervals for 1.5 h thereafter. Two baseline measurements were performed on 15 piglets (eight in control group and seven in indomethacin group); a single baseline measurement was performed on the remaining five piglets. The number of postindomethacin measurements performed ranged from six to eight. For the presentation of results, the end of the infusion period is assigned a time of 0 min such that the start of infusion is at Ϫ30 min and the baseline measurements are at Ϫ60 and/or Ϫ35 min.
NIRS tissue ICG concentration measurement. The NIRS system is composed of a tungsten halogen light source, two fiber optic cables, and a spectrometer. The spectrometer consists of a holographic grating housed in a custom-designed, light-tight container and a cooled CCD camera (Wright Instruments, Enfield, Middlesex, England). For the NIRS measurements, two fiber optic optodes were placed 3.0 cm apart on the head of the piglet. One of the optodes was used to transmit and the other to collect NIR light in the range 600 -980 nm. Multiply scattered light collected by the receive optode from the head of the piglet was relayed to the holographic grating, where it was dispersed across the cooled CCD chip (cooled to Ϫ70°C to reduce electronic dark noise). The piglets received a 1.0-mL injection of ICG solution at a concentration of 0.1 mg/mL into the ear vein. As discussed in the above theory, a modified version of the Beer-Lambert law, which uses the DPF (17) , discussed in "Theory" above, absolute Hb concentrations within the illuminated tissue region were determined from spectra acquired immediately before ICG administration. The reported absolute Hb concentrations were obtained by averaging Hb concentrations determined from individual spectrum over a 3-s period before ICG administration. All spectra were acquired with a temporal resolution of 200 ms.
Arterial ICG concentration measurement. Arterial ICG concentration was measured noninvasively on a hindfoot of the piglet using a Nihon Kohden dye densitogram unit (model DDG-2001 A/K, Tokyo, Japan). The dye densitogram probe was held on the skin of the piglet using a spring-loaded clip, much the same as is used for a regular pulse oximeter probe. The dye densitogram unit measured absolute ICG concentration in the arteries of the piglet, making one measurement every heartbeat. The normal piglet heart rate is between 110 and 130 beats/min, giving approximately one measurement every half-second (18) .
Statistical analysis and data presentation. Post-infusion CBF, CBV, MTT, CMRO 2 , and OEF measurements were compared with baseline measurements using two-way ANOVA with Tukey's test (27) . For piglets in which two baseline measurements were performed, baseline values were averaged before inclusion in Figures 2 and 3 . In Figures 3 and  4 , stars denote time points at which the mean CBF, CBV, MTT, CMRO 2 , or OEF value is significantly different from the corresponding baseline measurement (p Ͻ 0.05). (Fig. 1A) and treatment (Fig. 1B) piglets. No significant changes from baseline were observed in any physiologic parameter throughout the study. Figure 2 shows typical attenuation spectra acquired during ICG administration. Spectra were acquired immediately before ICG administration (a), during the arrival of ICG in brain tissue (b), and at peak ICG concentration (c). ICG exhibits a strong, broad absorption band centered at 805 nm (28) . Its presence and accumulation in the brain after bolus administration elicit increases in attenuation at approximately 805 nm, as observed in Figure 2 . Figure 3 presents average NIRS-measured CBF, CBV, and MTT for control and indomethacin-treated piglets, respectively, at baseline, immediately after administration of indomethacin/saline, and at 30-min intervals after administration of indomethacin/saline for a period of 90 min. No significant changes from baseline in any of CBF, CBV, or MTT were observed in control piglets throughout the study. In piglets treated with indomethacin, CBF decreased immediately after indomethacin infusion by an average of 8.0 mL · min Ϫ1 · 100 g Ϫ1 (18.1%) below baseline (p Ͻ 0.05). CBF subsequently returned to baseline within 60 min after indomethacin infusion. No significant changes in CBV from baseline were observed in piglets treated with indomethacin. MTT increased on average 1.2 s (29.8%) above baseline immediately after indomethacin infusion (p Ͻ 0.05) and remained slightly elevated for the remainder of the study. 
RESULTS

Figure 1 presents means and SDs of measured physiologic parameters in control
864
baseline were observed in control piglets throughout the study. In piglets treated with indomethacin, no significant changes in CMRO 2 from baseline were observed. However, OEF was significantly increased above baseline immediately after indomethacin infusion (average increase of 0.095 [17.3%] ; p Ͻ 0.05) and returned to baseline within 60 min after infusion.
DISCUSSION
The results presented in the current study suggest a compensatory increase of OEF to maintain normal CMRO 2 during reductions in CBF induced by indomethacin. CMRO 2 values reported in the current study are in agreement with those observed in previous newborn piglet studies (2, 29 -31 (2) found an average baseline CMRO 2 of 3.57 mL O 2 · min Ϫ1 · 100 g Ϫ1 in awake 3-to 5-d-old piglets using microsphere CBF determination and venous (sagittal sinus) blood samples. Although this value is higher than our reported baseline value, it is to be expected that awake piglets should have a higher CMRO 2 than those receiving anesthetics. Using microsphere-measured CBF and with arterial and venous (sagittal sinus) blood sampling, Ichord et al. (30) 2 values reported in the last study and those reported in the current study are likely due to differences in breed (mixed German domestic breed) and anesthetics used (nitrous oxide with isoflurane).
The ability to maintain CMRO 2 through increases in OEF is possible only when sufficient O 2 delivery is available. Piglets in the current study displayed comparatively high PaO 2 values with respect to those previously reported in the literature (29, 30) . Elevated PaO 2 values are indicative of elevated arterial O 2 content. Under conditions of decreased O 2 delivery, elevated arterial O 2 content provides an O 2 reserve for cerebral metabolism. It is likely through use of this O 2 reserve as well as through increases in OEF that the piglets studied were able to maintain constant CMRO 2 during indomethacin-induced reductions in CBF. The maintenance of CMRO 2 through increases in OEF during indomethacin-induced reductions in CBF may merit further consideration with respect to the clinical use of indomethacin. Increases in OEF suggest that the cerebral circulation may be entering an "unstable" phase, in which any further reductions in CBF or perfusion pressure may trigger a drop in CMRO 2 and ischemic damage, an important concern regarding the clinical use of indomethacin.
Whereas Benders et al. (5) and Pourcyrous et al. (2) both observed a decrease in CMRO 2 with indomethacin administration in preterm infants and newborn piglets (3-5 d old), respectively, our CMRO 2 measurements showed no effect with indomethacin administration. There are several reasons for this ambiguity. Benders et al. (5) used NIRS-measured concentration of Cyt during changes in CBV to infer CMRO 2 . The NIRS technique used, however, did not allow for determination of the DPF, discussed in "Theory" above, and therefore required the assumption of a constant pathlength. In the event that CBV remains constant, this assumption is relatively accurate, but under conditions of changing CBV, as reported in the same study, this assumption becomes invalid, preventing accurate determination of changes in chromophore concentration. Pourcyrous et al. (2) used higher doses of indomethacin (5 mg/kg) than the present study to elicit a drop in CMRO 2 , an observation also reported by Coyle et al. (7) in newborn piglets receiving similar indomethacin dose. However, in the same study, Coyle et al. (7) observed that lower dose indomethacin treatment (3 mg/kg) had no effect on CMRO 2 with concomitant trends of decreases in CBF and increases in OEF. Our results in newborn piglets receiving 0.2 mg/kg of indomethacin are consistent with those reported by Coyle et al. (7) . In a study investigating the cerebral hemodynamic and metabolic effects of indomethacin (20 mg/kg) in adult male baboons, Schumann et al. (32) used positron emission tomography to measure CMRO 2 and reported a decrease in CBF with concomitant increases in OEF and no significant changes in CMRO 2 with indomethacin infusion in brain regions matching those investigated in the current study. Although the absolute values of CBF, OEF, and CMRO 2 cannot be compared directly because age and species differences, the general trends of measured parameters presented in the current study are in agreement with those observed by Schumann et al. (32) .
The accuracy of any CMRO 2 measurement technique is dependent on the ability to measure accurately CBF, CaO 2 , and CvO 2 . The NIRS CBF measurement technique used in the present study has been previously validated in the newborn piglet in our laboratory (18) and is unlikely to contribute greatly to error in CMRO 2 measurement. CaO 2 measurement requires accurate arterial O 2 saturation data. In the present study, SaO 2 was derived from PaO 2 obtained from arterial blood samples using Kelman's conversion technique. This procedure involves the derivation of a "virtual" pH, PaCO 2 , and temperature-dependent O 2 dissociation curve, from which SaO 2 then can be determined. It has been shown to be accurate provided accurate measures of pH, PaCO 2 , PaO 2 , and temperature are available. Arterial blood gas samples were analyzed using standard techniques and therefore are unlikely to have generated undue error in our SaO 2 measurement. By far the largest source of error in the presented CMRO 2 values is that associated with the calculation of the arteriovenous O 2 difference. This calculation combines our NIRS CBV and absolute Hb concentration measurements to determine the amount of O 2 used in the region of the brain sampled with our NIRS technique. Although the concentration measurements themselves are relatively accurate, the necessary assumption that 70% of the cerebral circulation is in the venous compartment may lead to error in the arteriovenous O 2 difference determination as the ratio of arterial, capillary, and venous compartments may not remain constant during disturbances in cerebral hemodynamics. The presented CBV data showed no significant changes from baseline throughout the study, and it is unlikely that the ratio of arterial, capillary, and venous compartments could change without concomitant changes in CBV. Furthermore, a recent study by Lee et al. (33) investigating the venous and arterial contributions of total blood volume in the adult rat brain showed that an increase in total CBV of 31% above baseline values elicited an increase in the arterial CBV fraction of only 9%, from 20% to 29%. A brief analysis shows that such a redistribution of the arterial, capillary, and venous compartments, with 30% in the arterial, 10% in the capillary, and 60% in the venous compartment, introduces an error of only Ϯ 0.5 mL O 2 · min Ϫ1 · 100 g Ϫ1 in CMRO 2 values calculated using our technique. In addition, the observed increases in OEF immediately after indomethacin administration remain significant (p Ͻ 0.05) when calculations are performed using different CBV distribution ratios from 10%, 10%, and 80% to 30%, 10%, and 60% for arterial, capillary, and venous compartments, respectively. However, the inability to accurately measure this ratio remains a concern when the NIRS technique is applied to situations in which CBV need not remain constant. Improved knowledge regarding the venous contribution of the NIRS signal may be possible using a technique described by Franceschini et al. (34) in which the amplitude of respirationinduced oscillations in NIRS-measured ⌬Hb and ⌬HbO 2 concentrations is used to extract venous concentrations of ⌬HbO 2 and ⌬Hb. This approach will be investigated in our future work.
Because the NIRS CBF measurement technique has been previously validated and CaO 2 was determined using standard techniques, the presented study in effect investigates the ability of NIRS to measure CvO 2 . Because CaO 2 remained unchanged from baseline throughout the study, increases in OEF were the result of decreases in CvO 2 . A scenario in which CMRO 2 is maintained through compensatory increases in OEF during indomethacin-induced reductions in CBF, as was observed in the present study, provides an ideal means of investigating the ability of NIRS to measure changes in CvO 2 by isolating the parameter of interest. Furthermore, the effect of indomethacin is transient, with both CBF and OEF returning to baseline values, providing a means of assessing the capacity of NIRS to accurately measure both increases and decreases in CvO 2 .
CONCLUSION
The results presented in the current study provide evidence of the possibility of bedside, noninvasive measurement of CMRO 2 in the human infant. Whereas NIR light is able to penetrate biologic tissue relatively well, extracerebral structures such as bone and scalp detract from the amount of light interrogating cerebral tissue and thus introduce error in derived values. The technique described therefore is best suited for use in the newborn or preterm infant, in whom skull and scalp contributions are minimal. The ability to monitor changes in cerebral hemodynamics and metabolic rate, which are certainly present before clinically apparent manifestation of injury, at the bedside would allow for earlier diagnosis and possible prevention of cerebral injury in both the newborn and the preterm infant.
